HomeNewsBusinessEconomyExclusive | Commodity exports stopped India's trade from falling further in FY21

Exclusive | Commodity exports stopped India's trade from falling further in FY21

Latest data from the Commerce department for FY21 shows that relatively low value commodities, including both unprocessed raw materials and processed bulk goods, managed to hold their own throughout the pandemic-ridden year. A rise in global commodity prices and unused capacity due to drop in local manufacturing meant many commodity exports even managed to grow in 2020-21.

May 21, 2021 / 18:16 IST
Story continues below Advertisement
Warehouse. (Representational image)
Warehouse. (Representational image)

The 7.2 percent fall in India's exports during the pandemic-ridden 2020-21 financial year may have been much worse had it not been for a steady outflow of across the board commodity exports such as chemicals, ores, plastic, cotton and pulses steadying the trade figures.

Despite continuous government push over the past 5-years to increase exports of high-value manufactured goods across major markets, India’s export basket remains dominated by the commodities category.

Story continues below Advertisement

Ironically, this comes even as the Commerce Department has been aggressively trying to raise the share of value added manufactured goods in the overall export basket.

"We have believed for some years now that long term dependence on raw materials would be inherently detrimental to the export sector. At the least, it would rob the industry the chance to transition to higher value products, up the value chain," a senior Commerce Department official, said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show